Significance and Clinical Implications of Morphometric and Morphological Variability in Cadaveric Liver.

Background This study aimed to identify morphological variations, conduct morphometry of the liver, and present its clinical implications. Methodology The study was conducted on 35 preserved cadaveric livers without macroscopic abnormalities. Morphological features such as shape and size were studied and variations such as the absence of lobe, accessory fissures, or accessory lobes were noted in all specimens. Results The caudate lobe was absent in one liver, and the quadrate lobe was absent in six livers. Moreover, seven livers had accessory fissures, and accessory lobes were seen in six livers. The left lobe with a lingular process was seen in three livers, and diaphragmatic grooves were present in seven livers. Conclusions The present research is helpful to radiologists, surgeons, and anatomists as it demonstrates the different morphological variations in the liver.

Nanozymes: A comprehensive review on emerging applications in cancer diagnosis and therapeutics.

Nanozymes, a new class of nanomaterials-based artificial enzymes, have gained huge attraction due to their high operational stability, working efficiency in extreme conditions, and resistance towards protease digestion. Nowadays, they are effectively substituted for natural enzymes for catalysis by closely resembling the active sites found in natural enzymes. Nanozymes can compensate for natural enzymes' drawbacks, such as high cost, poor stability, low yield, and storage challenges. Due to their transforming nature, nanozymes are of utmost importance in the detection and treatment of cancer. They enable precise cancer detection, tailored drug delivery, and catalytic therapy. Through enhanced diagnosis, personalized therapies, and reduced side effects, their adaptability and biocompatibility can transform the management of cancer. The review focuses on metal and metal oxide-based nanozymes, highlighting their catalytic processes, and their applications in the prevention and treatment of cancer. It emphasizes their potential to alter diagnosis and therapy, particularly when it comes to controlling reactive oxygen species (ROS). The article reveals the game-changing importance of nanozymes in the future of cancer care and describes future research objectives, making it a useful resource for researchers, and scientists. Lastly, outlooks for future perspective areas in this rapidly emerging field have been provided in detail.

Recent progress in biomarker-based diagnostics of Helicobacter pylori, gastric cancer-causing bacteria.

The progression of any disease and its outcomes depend on the complicated interaction between pathogens, host and environmental factors. Thus, complete knowledge of bacterial toxins involved in pathogenesis is necessary to develop diagnostic methods and alternative therapies, including vaccines. This review summarizes recently employed biomarkers to diagnose the presence of Helicobacter pylori bacteria. The authors review distinct types of disease-associated biomarkers such as urease, DNA, miRNA, aptamers and bacteriophages that can be utilized as targets to detect Helicobacter pylori and, moreover, gastric cancer in its early stage. A detailed explanation is also given in the context of the recent utilization of these biomarkers in the development of a highly specific and sensitive biosensing platform.